Prestige to keep Dramamine and sell Bonine

4 September 2014 - Deborah Wilkes

Archived

Prestige Brands Holdings has completed the acquisition of US OTC company Insight Pharmaceuticals after agreeing to sell the Bonine motion-sickness brand to Wellspring Pharmaceutical.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: